Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular PreventionUdo Hoffmann, Robert T. OʼDonnell, Christie Lyn Costanza et al.|JAMA Network Open|2021Cited by 82
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE TrialPamela S. Douglas, Steven Grinspoon, Triin Umbleja et al.|Clinical Infectious Diseases|2021Cited by 41
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency VirusEmma M. Kileel, Steven Grinspoon, Janet Lo et al.|Open Forum Infectious Diseases|2021Cited by 38
Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIVJordan E. Lake, Carl J. Fichtenbaum, Jana Taron et al.|AIDS|2023Cited by 18
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease riskKathleen V. Fitch, Steven Grinspoon, Sara McCallum et al.|AIDS|2022Cited by 15